Increase in the vasorelaxant potency of K(ATP) channel opening drugs by adenosine A1 and A2 receptors in the pig coronary artery

European Journal of Pharmacology

Volumn 383, Issue 2, 1999, Pages 155-162

  Davie, C S ^a   Everitt, D E ^a   Standen, N B ^a  

^a Dept Cell Physiol Pharmacol U   (United Kingdom)

Author keywords

Adenosine; Coronary artery; K+ channel; Nicorandil

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 CHLOROADENOSINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; LEMAKALIM; NICORANDIL; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG POTENTIATION; ELECTROMYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SWINE;

ADENOSINE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CORONARY VESSELS; CROMAKALIM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; NICORANDIL; PHENETHYLAMINES; PINACIDIL; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, PURINERGIC P1; SWINE; TRIAZINES; TRIAZOLES; VASODILATOR AGENTS; XANTHINES;

EID: 0032760379     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00635-4     Document Type: Article

References (30)

1. ATP channels. Physiol. Rev. 78:1998;227-245.
2. 2 receptor mediated coronary vasodilation in dog. Cardiovasc. Res. 28:1994;906-911.
3. Bardenheuer H., Schrader J. Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am. J. Physiol. 250:1986;H173-H180.
4. Berne R.M. The role of adenosine in the regulation of coronary bloodflow. Circ. Res. 47:1980;807-813.
5. Collis M.G., Hourani S.M.O. Adenosine receptor subtypes. Trends Pharmacol. Sci. 14:1993;360-366.
6. Dart C., Standen N.B. Adenosine-activated potassium current in smooth muscle cells isolated from pig coronary artery. J. Physiol. 471:1993;767-786.
7. Davie C.S., Standen N.B. Enhancement of the vasorelaxant potency of nicorandil by metabolic inhibition and adenosine in the pig coronary artery. Cardiovasc. Res. 37:1998;791-798.
8. Davie C.S., Kubo M., Standen N.B. Potassium channel activation and relaxation by nicorandil in rat small mesenteric arteries. Br. J. Pharmacol. 125:1998;1715-1725.
9. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobsen K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
10. 1 adenosine receptor antagonist. Life Sci. 40:1987;555-563.
11. Holzmann S., Kukovetz W.R., Braida C., Poch G. Pharmacological interaction experiments differentiate between glibenclamide-sensitive potassium channels and cyclic GMP as components of vasodilation by nicorandil. Eur. J. Pharmacol. 215:1992;1-7.
12. + channel. J. Biol. Chem. 271:1996;24321-24324.
13. 2A receptor antagonist. Eur. J. Pharmacol. 301:1996;107-113.
14. 2 receptors and cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 92:1995;12441-12445.
15. 1 adenosine receptors. Naunyn-Scmiedebergs Arch. Pharmacol. 337:1988;687-689.
16. 1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. J. Pharmacol. Exp. Ther. 260:1992;437-443.
17. 2 adenosine receptor activity. Biochem. Biophys. Res. Commun. 168:1990;1297-1302.
18. Mulvany M.J., Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature. 260:1976;617-619.
19. Mulvany M.J., Aalkjaer C., Christensen J. Changes in noradrenaline sensitivity and morphology of arterial resistance vessels during development of high blood pressure in spontaneously hypertensive rats. Hypertension. 2:1980;664-671.
20. ATP channels. Am. J. Physiol. 273:1997;H2687-H2695.
21. + channel activation. Am. J. Physiol. 265:1993;H1289-H1293.
22. Quayle J.M., Nelson M.T., Standen N.B. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol. Rev. 77:1997;1165-1232.
23. Randall M.D. Involvement of ATP-sensitive potassium channels and adenosine in the regulation of coronary flow in the isolated perfused rat heart. Br. J. Pharmacol. 116:1995;3068-3074.
24. Randall M.D., Griffith T.M. Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil. Br. J. Pharmacol. 109:1993;386-393.
25. Randall M.D., Ujiie H., Griffith T.M. Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation. Br. J. Pharmacol. 112:1994;49-54.
26. Satoh E., Yamada M., Kondo C., Repunte V.P., Horio Y., Ijima T., Kurachi Y. Intracellular nucleotide-mediated gating of SUR/Kir6.0 complex potassium channels expressed in a mammalian cell line and its modification by pinacidil. J. Physiol. 51:1998;663-674.
27. + channels by pinacidil and nicorandil. Br. J. Pharmacol. 124:1998;985-991.
28. ATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of sulphonylurea receptor. J. Gen. Physiol. 110:1997;643-654.
29. + channel-opening drugs. Am. J. Physiol. 26:1995;C525-C545.
30. White T.D., Angus J.A. Relaxant effects of ATP and adenosine on canine large and small coronary arteries in vitro. Eur. J. Pharmacol. 143:1987;119-126.